Skip to main content
. 2012 May 1;14(3):500–509. doi: 10.1208/s12248-012-9363-4

Fig. 4.

Fig. 4

Formation of VEGF/VEGFR2 complexes in response to isoform-specific anti-VEGF treatment. The number of VEGF/VEGFR2 complexes in the normal tissue, blood, and tumor is calculated following isoform-specific VEGF treatments: a Pan anti-VEGF. b Anti-VEGF121 agent. c Anti-VEGF165 agent